Propranolol Hydrochloride Injection Shortage: Current Availability and Manufacturer Updates
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA reports a current shortage of Propranolol Hydrochloride Injection due to shipping delays, with the primary manufacturer reporting unavailability until March 2026.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Propranolol Hydrochloride.
What's in Shortage
Propranolol Hydrochloride Injection (Brand Name: PROPRANOLOL) is currently listed in a shortage status. This medication is an injection within the Cardiovascular therapeutic category. The shortage specifically affects the 1 mg/1 mL dosage form.
Which Manufacturers Are Affected
According to the latest data, the following manufacturer is impacted:
- Fresenius Kabi USA, LLC
- Status: Unavailable
- Presentation: Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01)
- Notes: The next release is currently estimated for March 2026. The manufacturer suggests checking with wholesalers for any existing inventory.
- Contact Information: 888-386-1300
Why There's a Shortage
The reason provided for this shortage is a delay in shipping of the drug.
What Patients Should Do
If you or a loved one are prescribed Propranolol Hydrochloride Injection, please consider the following steps:
- Consult Your Healthcare Provider: Speak with your doctor immediately to discuss your treatment plan and any necessary clinical adjustments during this shortage.
- Contact Your Pharmacist: Inquire about current stock levels or if they can source the medication from alternative wholesalers.
- Contact the Manufacturer: You may use the contact information listed above to ask for updates regarding supply availability.
Disclaimer: This article is for informational purposes only. Patients should always consult their healthcare provider for medical advice and before making any changes to their medication regimen.
Source
This information is sourced from the FDA Drug Shortage Database.
- Initial Posting Date: 10/31/2023
- Last Updated: 02/05/2026
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.